The protein expression of RAD52, RAD50, PBX2, MAP2K2 (MEK2), and S100P was also validated with immunohistochemistry in invasive breast cancer tumor tissues (Figure S6 in Supplementary File S1). The gene discussed is PBX2; the disease is breast carcinoma.